reports
Meridian Corporation Reports First Quarter 2025 Results and Announces ...
Meridian Corporation Reports First Quarter 2025 Results and Announces a Quarterly Dividend of $0.125 per Common Share MALVERN, Pa., April 25, 2025 (GLOBE NEWSWIRE) -- Meridian Corporation (Nasdaq: MRBK) today reported: Three Months Ended(Dollars in thousands, except per share data)((Unaudited)March 31,2025 December 31,2024 March 31,2024Income: Net income$2,399 $5,600 $2,676Diluted earnings per common share$0.21 $0.49 $0.24Pre-provision net revenue (PPNR) (1)$8,357 $11,167 $6,419(1) See Non-GAAP reconciliation in the Appendix Net income for the quarter ended March 31, 2025...
Enphase Energy Reports Financial Results for the First Quarter of 2025
Enphase Energy Reports Financial Results for the First Quarter of 2025 FREMONT, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today financial results for the first quarter of 2025, which included the summary below from its President and CEO, Badri Kothandaraman. We reported quarterly revenue of $356.1 million in the first quarter of 2025, along with 48.9% for non-GAAP gross margin. We shipped approximately 1.53 million microinverters, or 688.5 mega...
Enphase Energy Expands in Europe with IQ Battery 5P with FlexPhase, De...
Enphase Energy Expands in Europe with IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Power in Poland FREMONT, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of its most powerful and versatile battery yet, the IQ® Battery 5P with FlexPhase, for customers in Poland. The IQ Battery 5P with FlexPhase is an all-in-one AC-coupled system that delivers reliable backup power and supports both single-phase and three-phase applicat...
Enphase Energy Expands in Europe with IQ Battery 5P with FlexPhase, De...
Enphase Energy Expands in Europe with IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Power in Luxembourg FREMONT, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of its most powerful and versatile battery yet, the IQ® Battery 5P with FlexPhase, for customers in Luxembourg. The IQ Battery 5P with FlexPhase is an all-in-one AC-coupled system that is designed to deliver reliable backup power and supports three-phase electric...
Enphase Energy Announces Conference Call to Review First Quarter 2025 ...
Enphase Energy Announces Conference Call to Review First Quarter 2025 Financial Results Tuesday, April 22, 2025 at 4:30 p.m. Eastern Time FREMONT, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today that it will host a conference call and webcast on Tuesday, April 22, 2025 at 4:30 p.m. Eastern Time to discuss its first quarter 2025 financial results for the period ended March 31, 2025. The live webcast can be accessed on the Enphase Energy Invest...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, April 04, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on April 1, 2025, the Compensation Committee of Taysha's Board of Directors granted five new employees, in the aggregate, options to purchase 822,000 shares of the Company's common stock in connectio...
Enphase Energy Adds Battery Backup to Boost Resilience in France and t...
Enphase Energy Adds Battery Backup to Boost Resilience in France and the Netherlands FREMONT, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the introduction of the IQ® System Controller in France and the Netherlands. This advanced system integrates Enphase's IQ® Microinverters and IQ® Battery 5Ps to provide a comprehensive energy solution that enables homeowners to seamlessly transition to backup power during grid outages, ensuring continuous ...
Enphase Energy Assists SunPower Customers with Monitoring and Service ...
Enphase Energy Assists SunPower Customers with Monitoring and Service Solutions FREMONT, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that more than 2,500 SunPower customers have transitioned to Enphase monitoring since SunPower’s bankruptcy filing in August 2024. Several hundred thousand SunPower customers currently use its proprietary PV Supervisor communications gateway for monitoring. Many of these systems are built with Enphase microinv...
Centessa Pharmaceuticals Reports Business Highlights and Financial Res...
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024 Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise with key data readouts expected in 2025 ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) well underway and on track with data expected across all three indications in 2025 with first-in-class potential in NT2 and IHORX142 in IND-enabling studies for the treatment of neurological and neurodegenerative disorde...
Enphase Energy Applauds New Rapid Shutdown Standard for Solar Installa...
Enphase Energy Applauds New Rapid Shutdown Standard for Solar Installations in Brazil FREMONT, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today commended the introduction of Brazil's new fire safety standard, Brazilian Association of Technical Standards (ABNT) NBR 17193, which outlines stringent recommendations like rapid shutdown functionality requirements for solar installations in all buildings. The new standard emphasizes the importance of safety in s...
Enphase Energy Launches Next-Generation IQ EV Charger across Europe
Enphase Energy Launches Next-Generation IQ EV Charger across Europe FREMONT, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced production shipments of its newest electric vehicle (EV) charger, the IQ® EV Charger 2, in 14 European markets. The IQ EV Charger 2 is a smart charger designed to work seamlessly with Enphase solar and battery systems or as a powerful standalone charger. With advanced energy management features, the charger empowers homeow...
Enphase Energy Inc: 1 director
A director at Enphase Energy Inc sold 100,000 shares at 61.257USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, March 07, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) ("Taysha" or the "Company"), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on March 3, 2025, the Compensation Committee of Taysha's Board of Directors granted three new employees, in the aggregate, options to purchase 225,000 shares of the Company's common stock in conn...
Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clin...
Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting BOSTON and LONDON, March 06, 2025 (GLOBE NEWSWIRE) -- plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that data from the Phase 1 clinical trial of ORX750, an investigational novel highly potent and selective OX2R agonist being progressed for the treatment of narcolepsy type 1 (NT1), n...
Enphase Energy Increases Deployments of Legacy NEM System Expansion So...
Enphase Energy Increases Deployments of Legacy NEM System Expansion Solution in California California utilities streamline approval process for legacy NEM system expansions FREMONT, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced increased deployments of its solution for expanding legacy net energy metering (NEM) solar energy systems in California as utilities streamline their approval process. Homeowners can now expand their systems without l...
Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Pro...
Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update High dose and low dose of TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in all pediatric, adolescent and adult patients treated (high dose, n=6; low dose, n=4) across both REVEAL trials as of February 2025 data cutoff Completed dosing of the 10 patients in Part A of both REVEAL trials; maturing dataset continues to support advancement toward pivotal Part B trial Productive ongoing discussions with the FDA to solidify regulatory pathway for TSHA-102; update...
- Jonathan Moreland
WYNN WYNN RESORTS LIMITED
TTSH TILE SHOP HOLDINGS INC.
OXBR OXBRIDGE RE HOLDINGS
NGL NGL ENERGY PARTNERS LP
HMC HARMONIC
HII HUNTINGTON INGALLS INDUSTRIES INC.
EL ESTEE LAUDER COMPANIES INC. CLASS A
CVS CVS HEALTH CORPORATION
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
BZH BEAZER HOMES USA INC.
BMY BRISTOL-MYERS SQUIBB COMPANY
ASYS AMTECH SYSTEMS INC.
ARCC ARES CAPITAL CORPORATION
AIG AMERICAN INTERNATIONAL GROUP INC.
MDU MDU RESOURCES GROUP INC
CMCO COLUMBUS MCKINNON CORPORATION
USFD US FOODS HOLDING CORP.
FRD FRIEDMAN INDUSTRIES INC.
PLBC PLUMAS BANCORP
FBK FB FINANCIAL CORPORATION
MRUS MERUS B V
PFE PFIZER INC.
XFLT XAI OCTAGON FLOATING RATE ALTERNATIVE INCOME TERM TRUST
RCUS ARCUS BIOSCIENCES
NWPP NEW PEOPLES BANKSHARES INC.
EAF GRAFTECH INTERNATIONAL
AMCR AMCOR PLC
BFC BANK FIRST NATIONAL CORP
CBKM CONSUMERS BANCORP INC.
IDYA IDEAYA BIOSCIENCES
RZLT REZOLUTE
REYN INC.
MTCH REYNOLDS CONSUMER PRODUCTS INC.
ESOA MATCH GROUP INC.
ATAI ENERGY SERVICES OF AMERICA CORP.
FLNC ATAI LIFE SCIENCES BV
BST FLUENCE ENERGY INC
PCT BLACKROCK SCIENCE AND TECHNOLOGY TRUST
CMPO PURECYCLE TECHNOLOGIES INC
EFSI COMPOSECURE INC
LSMG EAGLE FINANCIAL SERVICES INC
SLDB LODE STAR MINING INC
RCEL SOLID BIOSCIENCES INC
MNR AVITA MEDICAL INC
OCX MACH NATURAL RESOURCES LP
FDBC ONCOCYTE CORPORATION
FIDELITY D & D BANCORP INC
- Jonathan Moreland
- Jonathan Moreland
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.